This Month in Muscular Dystrophy   /     Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015

Description

Guest: Jerry Mendell, MD, is Director of the Center for Gene Therapy in The Research Institute, Director of the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, and Curran-Peters Chair of Pediatric Research at Nationwide Children’s Hospital. He is also an attending neurologist at Nationwide Children’s and a professor of pediatrics and neurology at The Ohio State University College of Medicine. • View the published abstract for this month’s featured research article. • Learn more about the gene therapy trial for Becker Muscular Dystrophy.

Subtitle
Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015
Duration
14:39
Publishing date
2015-03-23 19:17
Link
http://www.nationwidechildrens.org/jerry-mendell-discusses-phase-12a-follistatin-gene-therapy-trial-for-becker-muscular-dystrophy
Contributors
  Kevin Flanigan, MD
author  
Enclosures
http://sas-origin.OnstreamMedia.com/origin/nationwidechildrens/Research/jerry-mendell-discusses-phase-1-2a-follistatin-gene-therapy-trial-for-becker.mp3
audio/mpeg